National medical special zone · Licensed early access to global drugs & devices
Boao Super Hospital (Boao Lecheng International Medical Tourism Pilot Zone)
Lung cancerBreast cancerLymphomaLeukemiaColorectal cancer
Established
2018
Beds
500+
Annual Volume
20,000+
Boao, Hainan
Under national licensed-care policies, cancer patients can access the latest oncology drugs and devices approved overseas but not yet in mainland China, with Hainan’s visa-free entry.
About the Hospital
Boao Super Hospital is located in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan. Under national special-access policies, it can use innovative drugs and devices approved overseas but not yet in mainland China — a key bridge between patients in China and global novel therapies.
The hospital operates under a “1+X” model jointly run by multiple academician teams across oncology, rare diseases and ophthalmology; special-access approvals are fast (usually a few working days), with real-world-data research pathways.
Hospital Strengths
01The special-access drug and device channel
The only zone in mainland China where overseas-approved but not-yet-domestically-approved innovative drugs and devices can be legally used, covering hundreds of oncology, immunology and rare-disease products.
02An academician co-building model
Specialty teams led by multiple academicians are based here, offering one-stop access to top experts and special-access medication.
03A real-world research platform
Special-access usage data feed real-world research, accelerating some products toward full approval in China.
Key Departments
Cancer CenterRare Disease CenterInternational Medical DepartmentPharmacy (Special Access)
Coordinated Treatment Directions
01Special access to overseas innovative oncology drugs
02Special-access therapy for rare diseases
03Real-world research on special-access products
04International medical tourism and health management
Officially Reported Treatment Milestones
Early-access clinical application of international innovative drugs and devices
2019–
Leveraging the Boao Lecheng pilot-zone policy and its “1+X” platform model, it has delivered multiple first-in-China clinical applications of international innovative drugs and devices in oncology.
Accreditations & Platforms
Core platform of the State Council-approved international medical tourism pilot zone
Pilot site for licensed import of urgently needed drugs & devices